510(k) K771562

AGGLUTINATING SERUM W135 by Burroughs Wellcome Co. — Product Code GTJ

K771562 is an FDA 510(k) premarket notification submitted by Burroughs Wellcome Co. for the device "AGGLUTINATING SERUM W135". The FDA issued a decision of Substantially Equivalent on August 25, 1977. The device falls under product code GTJ (Antisera, All Groups, N. Meningitidis), a Class II device regulated under 21 CFR 866.3390. Burroughs Wellcome Co. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 25, 1977
Date Received
August 15, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antisera, All Groups, N. Meningitidis
Device Class
Class II
Regulation Number
866.3390
Review Panel
MI
Submission Type